Young Do Jung Selected Research

RON protein

1/2020	Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells.
9/2017	Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression.
9/2016	MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais.
4/2015	Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells.
3/2013	EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.
2/2011	MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
9/2010	Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Do Jung Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 05/2002
15	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2002
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2002
6	Carcinogenesis 01/2022 - 09/2007
6	Colonic Neoplasms (Colon Cancer) 05/2020 - 04/2002
5	Inflammation (Inflammations) 04/2022 - 03/2012
4	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 09/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 07/2018
2	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 05/2018
2	Carcinoma (Carcinomatosis) 01/2020 - 10/2002
2	Hypoxia (Hypoxemia) 07/2019 - 10/2002
2	Atherosclerosis 01/2019 - 01/2002
2	Fibrosarcoma 01/2009 - 12/2002
1	Hyperammonemia 04/2022
1	Hepatic Encephalopathy 04/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022
1	Atrophic Gastritis 01/2022
1	Metaplasia 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Non-Muscle Invasive Bladder Neoplasms 07/2019
1	Papillary Thyroid Cancer 11/2018
1	Papillary Thyroid Microcarcinoma 11/2018
1	Retinoblastoma (Glioblastoma, Retinal) 09/2016
1	Peptic Ulcer (Peptic Ulcers) 04/2014
1	Ulcer 04/2014
1	Gastritis 04/2014

Drug/Important Bio-Agent (IBA)

9	Urokinase Plasminogen Activator ReceptorsIBA 01/2020 - 06/2008
8	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2021 - 06/2008
7	RON proteinIBA 01/2020 - 09/2010
6	Bile Acids and Salts (Bile Acids)IBA 03/2022 - 04/2010
4	Interleukin-8 (Interleukin 8)IBA 03/2022 - 12/2013
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2002
4	Small Interfering RNA (siRNA)IBA 01/2015 - 01/2009
3	Lithocholic AcidIBA 03/2022 - 04/2010
3	FlavonoidsIBA 01/2021 - 01/2002
3	PhytochemicalsIBA 01/2021 - 04/2015
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2020 - 09/2013
3	CarcinogensIBA 11/2018 - 12/2015
3	NF-kappa B (NF-kB)IBA 09/2010 - 06/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 11/2018
2	piperineIBA 03/2022 - 01/2015
2	Cholic AcidIBA 01/2022 - 05/2020
2	Biological ProductsIBA 11/2020 - 12/2007
2	Docosahexaenoic AcidsIBA 01/2020 - 01/2016
2	lysophosphatidic acidIBA 01/2020 - 06/2008
2	CytokinesIBA 01/2019 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 10/2002
2	Messenger RNA (mRNA)IBA 09/2016 - 12/2002
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2016 - 09/2010
2	MicroRNAs (MicroRNA)IBA 09/2016 - 09/2014
2	CadmiumIBA 12/2015 - 10/2014
2	p38 Mitogen-Activated Protein KinasesIBA 01/2015 - 12/2002
2	TeaIBA 03/2013 - 01/2002
1	MelatoninIBA 04/2022
1	AmmoniaIBA 04/2022
1	AcidsIBA 03/2022
1	Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA 01/2022
1	SmokeIBA 10/2021
1	Nicotine FDA Link 10/2021
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2021
1	Nitrogen CompoundsIBA 01/2021
1	SteroidsIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	sulforaphaneIBA 07/2019
1	Oxygen (Dioxygen)IBA 07/2019
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	ErbB Receptors (EGF Receptor)IBA 11/2018
1	ApigeninIBA 07/2018
1	Glycoproteins (Glycoprotein)IBA 07/2018
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2018
1	ceric oxide (cerium dioxide)IBA 05/2018
1	PowdersIBA 05/2018
1	OxidesIBA 05/2018
1	potassium niobateIBA 05/2018
1	Contrast MediaIBA 05/2018
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	Cyclin D3IBA 09/2016
1	Cyclin D1IBA 09/2016
1	AntioxidantsIBA 01/2016
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2016
1	InterleukinsIBA 01/2016
1	tricarbonyldichlororuthenium (II) dimerIBA 01/2016
1	Carbon MonoxideIBA 01/2016
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2015
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	chrysinIBA 04/2015
1	AlkaloidsIBA 01/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2015
1	Tetracycline (Achromycin)FDA LinkGeneric 09/2014
1	TetraspaninsIBA 09/2014
1	Ethanol (Ethyl Alcohol)IBA 04/2014
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2014
1	ElementsIBA 03/2013

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2002
1	Precision Medicine 11/2020
1	Neck Dissection (Radical Neck Dissection) 11/2018